[1]
A. G. Elnahry and G. A. Elnahry, “REVERSIBLE NEUROTHROPHIC KERATOPATHY ASSOCIATED WITH ROSUVASTATIN THERAPY: A CASE REPORT”, J Popl Ther Clin Pharmacol, vol. 26, no. 2, pp. e38-e42, Aug. 2019, doi: 10.15586/jptcp.v26i2.627.